###begin article-title 0
###xml 41 68 41 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mycobacterium tuberculosis </italic>
###xml 136 138 136 138 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 41 67 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
Dimerization of inositol monophosphatase Mycobacterium tuberculosis SuhB is not constitutive, but induced by binding of the activator Mg2+
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 17 44 17 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mycobacterium tuberculosis </italic>
###xml 496 512 496 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 17 43 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
###xml 366 371 <span type="species:ncbi:9606">Human</span>
###xml 496 511 <span type="species:ncbi:1773">M. tuberculosis</span>
The cell wall of Mycobacterium tuberculosis contains a wide range of phosphatidyl inositol-based glycolipids that play critical structural roles and, in part, govern pathogen-host interactions. Synthesis of phosphatidyl inositol is dependent on free myo-inositol, generated through dephosphorylation of myo-inositol-1-phosphate by inositol monophosphatase (IMPase). Human IMPase, the putative target of lithium therapy, has been studied extensively, but the function of four IMPase-like genes in M. tuberculosis is unclear.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 72 88 72 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 318 320 318 320 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 404 407 404 407 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 520 522 520 522 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 549 551 549 551 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 72 87 <span type="species:ncbi:1773">M. tuberculosis</span>
We determined the crystal structure, to 2.6 A resolution, of the IMPase M. tuberculosis SuhB in the apo form, and analysed self-assembly by analytical ultracentrifugation. Contrary to the paradigm of constitutive dimerization of IMPases, SuhB is predominantly monomeric in the absence of the physiological activator Mg2+, in spite of a conserved fold and apparent dimerization in the crystal. However, Mg2+ concentrations that result in enzymatic activation of SuhB decisively promote dimerization, with the inhibitor Li+ amplifying the effect of Mg2+, but failing to induce dimerization on its own.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 21 23 21 23 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 191 193 191 193 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 231 234 231 234 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 336 338 336 338 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 341 342 341 342 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 555 558 555 558 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
The correlation of Mg2+-driven enzymatic activity with dimerization suggests that catalytic activity is linked to the dimer form. Current models of lithium inhibition of IMPases posit that Li+ competes for one of three catalytic Mg2+ sites in the active site, stabilized by a mobile loop at the dimer interface. Our data suggest that Mg2+/Li+-induced ordering of this loop may promote dimerization by expanding the dimer interface of SuhB. The dynamic nature of the monomer-dimer equilibrium may also explain the extended concentration range over which Mg2+ maintains SuhB activity.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 37 40 37 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">myo</italic>
###xml 224 226 224 226 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 272 275 272 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink">myo</italic>
###xml 298 299 298 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 355 358 355 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink">myo</italic>
###xml 474 475 474 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 492 495 492 495 <italic xmlns:xlink="http://www.w3.org/1999/xlink">myo</italic>
###xml 719 720 719 720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
The enzyme inositol monophosphatase (myo-inositol-1-phosphate phosphohydrolase, EC 3.1.3.25, IMPase) has attracted considerable scrutiny since the early 1980s. Then, it was discovered that low millimolar concentrations of Li+ inhibit IMPase-catalysed dephosphorylation of myo-inositol-1-phosphate [1], which could plausibly explain the marked decrease of myo-inositol in brain tissue following administration of lithium, a veteran therapeutic in manic depression treatment [2]. Inhibition of myo-inositol synthesis affects the phosphatidyl inositol second messenger pathway, which is linked to manic depression, and it is now widely accepted, though unproven, that IMPases constitute a major target of lithium therapy [3].
###end p 9
###begin p 10
###xml 202 203 202 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 366 367 366 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 368 369 368 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 460 476 460 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 510 513 510 513 <italic xmlns:xlink="http://www.w3.org/1999/xlink">myo</italic>
###xml 524 525 524 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 559 562 559 562 <italic xmlns:xlink="http://www.w3.org/1999/xlink">myo</italic>
###xml 619 627 619 627 <italic xmlns:xlink="http://www.w3.org/1999/xlink">de novo </italic>
###xml 836 837 836 837 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 935 959 935 959 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mycobacterium smegmatis </italic>
###xml 1100 1102 1100 1102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 460 475 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 935 958 <span type="species:ncbi:1772">Mycobacterium smegmatis</span>
The mycobacterial cell wall contains several lipid constituents based on the structure of phosphatidylinositol (PI), such as free PI, phosphatidylinositol-mannosides, lipomannan, and lipoarabinomannan [4]. In addition to their critical structural role, these lipids are significant as immunomodulatory factors in interactions of the tubercle bacillus with the host [5-7]. PI, an essential structural component, is synthesised by phosphatidylinositol synthase, M. tuberculosis PgsA, from CDP-diacylglycerol and myo-inositol [8]. In mycobacteria, the supply of myo-inositol to PI synthesis is thought to be maintained by de novo synthesis, which entails conversion of glucose-6-phosphate to inositol-1-phosphate, catalysed by inositol-1-phosphate synthase, and subsequent dephosphorylation of inositol-1-phosphate catalysed by an IMPase [9]. Thus, IMPase activity is a critical part of PI biosynthesis in mycobacteria. Indeed, growth of Mycobacterium smegmatis is accompanied by IMPase activity that dies off as growth reaches the stationary phase, while growth is retarded in the presence of lithium [10].
###end p 10
###begin p 11
###xml 4 20 4 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 66 67 66 67 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 70 72 70 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 73 75 73 75 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 159 175 159 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 248 264 248 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 374 382 374 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 392 400 392 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 478 480 478 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 535 551 535 551 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 615 620 615 620 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 665 667 665 667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 743 752 743 752 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vitro </italic>
###xml 773 789 773 789 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 882 884 882 884 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 921 931 921 931 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bona fide </italic>
###xml 1175 1177 1175 1177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 1230 1232 1230 1232 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1315 1318 1315 1318 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 1472 1474 1472 1474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 1634 1650 1634 1650 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 4 19 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 159 174 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 219 224 <span type="species:ncbi:9606">human</span>
###xml 248 263 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 374 381 <span type="species:ncbi:562">E. coli</span>
###xml 392 399 <span type="species:ncbi:562">E. coli</span>
###xml 535 550 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 773 788 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 1189 1194 <span type="species:ncbi:9606">human</span>
###xml 1634 1649 <span type="species:ncbi:1773">M. tuberculosis</span>
The M. tuberculosis genome encodes four IMPase-like genes (Figure 1) [11,12], but little is known about the function of the corresponding proteins in terms of M. tuberculosis biology. The enzyme most closely related to human IMPase (25% identity), M. tuberculosis SuhB (Rv2701c), has been annotated as a 'putative extragenic suppressor protein' according to its homology to E. coli SuhB. The E. coli enzyme has been implicated in posttranscriptional control of gene expression [13], but no such function has to date been described for M. tuberculosis SuhB. According to the transposon mutagenesis study by Sassetti et al., Rv3137 is essential, SuhB is dispensable [14], and information on essentiality is as yet unavailable for CysQ and ImpA. In vitro analyses showed that M. tuberculosis CysQ hydrolyses inositol-1-phosphate, adenosine-monophosphate and fructose-1,6-bisphosphate [15]. In contrast, SuhB appears to be a bona fide IMPase with little or no activity towards fructose-1,6-bisphosphate. Still, SuhB also de-phosphorylates a series of polyol phosphates including glucitol-6-phosphate, glycerol-2-phosphate, and 2'-AMP, albeit with significantly reduced efficacy [12]. Like the human orthologue, SuhB is activated by Mg2+, and inhibited by lithium. Nevertheless, SuhB requires higher concentrations of Mg2+ for full activation (at ~6 mM), and activity persists over a much wider concentration range (~100 mM) of the activating ion before it becomes inhibitory [12]. In order to better understand potential functional differences between the mycobacterial and eukaryotic IMPases, we have determined the crystal structure of M. tuberculosis SuhB and characterised its self-assembly state in solution.
###end p 11
###begin p 12
###xml 23 39 23 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 0 77 0 77 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Sequence comparison of <italic>M. tuberculosis </italic>IMPase-like proteins with human IMPase</bold>
###xml 427 430 424 427 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 23 38 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 65 70 <span type="species:ncbi:9606">human</span>
###xml 154 159 <span type="species:ncbi:9606">human</span>
###xml 706 711 <span type="species:ncbi:9606">human</span>
Sequence comparison of M. tuberculosis IMPase-like proteins with human IMPase. Sequences were aligned based on the structural superimposition of SuhB and human IMPase using STRAP [53], and formatted using ESPript [54]. Secondary structure elements of SuhB are above the sequence, cylinders representing helices and arrows beta-strands, coloured according to Fig. 2A. Full asterisks denote residues coordinating the catalytic Mg2+ sites, triangles indicate residues contacting inositol-1-phosphate in the simulated SuhB-substrate complex. Horizontal boxes indicate disordered parts of the sequence. The grey arrows indicate the positions of strands beta1, beta2 in the alpha1-alpha2 loop ('mobile loop') of human IMPase, with the open asterisk marking the critical lysine residue.
###end p 12
###begin title 13
Results
###end title 13
###begin title 14
Structure determination of SuhB
###end title 14
###begin p 15
###xml 110 111 110 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 120 121 120 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 484 485 484 485 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 593 594 593 594 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 603 604 603 604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 767 768 767 768 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 879 880 879 880 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 17 32 <span type="species:ncbi:1773">M. tuberculosis</span>
The structure of M. tuberculosis SuhB was determined by molecular replacement to a resolution of 2.6 A (Table 1, Figure 2). The asymmetric unit of the crystal lattice contains three independent copies of the SuhB monomer forming two crystallographically distinct dimers: chains A and C associate as one dimer, whereas chain B forms an analogous dimer with one of its symmetry mates. The quality of the refined model is limited by several factors: first, a high Wilson B-factor (77.1 A2) of the measured structure factor amplitudes is mirrored by a high average atomic displacement factor (78 A2) (Table 1); second, three disordered loop regions (see below) and mild disorder at either terminus leave 42 of 290 residues of the primary sequence unaccounted for (Figure 1); third, despite a nominal resolution of 2.6 A and reasonably strong data in the high-resolution shell (Table 1), structural details are less well defined by the (calculated) density than expected at this resolution. In order to counteract an unfavourable observables-to-parameter ratio, non-crystallographic symmetry (NCS) restraints were employed, leading to root mean square (RMS) deviations between NCS-related molecules of 0.05 A for backbone and </= 0.42 A for side chain atoms. Based on visual impression and real space R-factor, the electron density is best defined for subunits A and C, and worst for subunit B.
###end p 15
###begin p 16
Crystallographic statistics
###end p 16
###begin p 17
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a </sup>
a Numbers in parenthesis refer to the outer resolution bin.
###end p 17
###begin p 18
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b </sup>
###xml 14 15 10 11 <sub xmlns:xlink="http://www.w3.org/1999/xlink">h</sub>
###xml 20 22 12 14 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i </sub>
###xml 49 50 37 38 <sub xmlns:xlink="http://www.w3.org/1999/xlink">h</sub>
###xml 55 57 39 41 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i </sub>
b Rsym = SigmahSigmai | I(h, i) - < I(h) >|/SigmahSigmai I(h, i), where I(h, i) is the intensity of the ith measurement of reflection h and < I(h) > is the mean value of I(h, i) for all i measurements.
###end p 18
###begin p 19
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">c </sup>
###xml 16 19 12 15 <sub xmlns:xlink="http://www.w3.org/1999/xlink">hkl</sub>
c Rcryst = Sigmahkl||Fo| - |Fc||/Sigma |Fo|, where Fo is the observed structure-factor amplitude and Fc the calculated structure-factor amplitude. Rfree is calculated based on 5% of reflections not used in the refinement.
###end p 19
###begin p 20
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">d </sup>
###xml 45 54 45 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PROCHECK </italic>
d The Ramachandran plot was calculated using PROCHECK [43]
###end p 20
###begin p 21
###xml 26 42 26 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 0 46 0 46 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Fold and crystal dimer of <italic>M. tuberculosis </italic>SuhB</bold>
###xml 49 50 49 50 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 242 243 224 225 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 26 41 <span type="species:ncbi:1773">M. tuberculosis</span>
Fold and crystal dimer of M. tuberculosis SuhB. (A) Stereo ribbon diagram of the SuhB monomer, with secondary structure elements coloured according to the penta-layered alphabetaalphabetaalpha-sandwich arrangement of IMPases (cf. Figure 1). (B) Dimer of SuhB formed by subunits A (blue, yellow) and C (lightblue, green). Selected secondary structure elements are labelled for ease of comparison with panel A. Grey spheres indicate boundaries of disordered loops, with corresponding residue numbers in black type. A (modelled) molecule of inositol-1-phosphate in ball-and-stick representation indicates the location of the active site(s) in both panels.
###end p 21
###begin p 22
###xml 93 95 93 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 96 98 96 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 219 220 215 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 406 407 402 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 412 414 408 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 417 419 413 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 573 575 544 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 874 875 845 846 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 998 1000 969 971 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 1001 1003 972 974 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 1152 1154 1123 1125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 1155 1157 1126 1128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 1158 1160 1129 1131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 1246 1248 1217 1219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1249 1251 1220 1222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 1252 1254 1223 1225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 1255 1257 1226 1228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 1315 1335 1286 1306 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Thermotoga maritima </italic>
###xml 1363 1365 1334 1336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 1366 1368 1337 1339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 383 389 <span type="species:ncbi:9913">bovine</span>
###xml 1315 1334 <span type="species:ncbi:2336">Thermotoga maritima</span>
Apart from minor discrepancies, the SuhB monomer is identical in fold to eukaryotic IMPases [16,17], with RMS deviations between Calpha positions of superimposed backbone structures ranging from 1.09 A to 1.15 A (Table 2). In order to more readily compare SuhB with related structures we denote secondary structure according to the recent report of the 1.4 A-resolution structure of bovine IMPase (Figures 1 and 2A) [17]. The IMPase fold is characterised by alternating layers of alpha-helices and beta-sheets in an alpha-beta-alpha-beta-alpha sandwich arrangement (Figure 2A). Comparative studies established that IMPases share a structural scaffold with inositol polyphosphate-1-phosphatases (IPPases), fructose-1,6-biphosphatases (FBPases), 3'-phosphoadenosine-5'-phosphatases (PAPases) and 3'-phosphoadenosine-5'-phosphatase/inositol-1,4-bisphophatases (PIPases) (Table 2), although on the amino acid sequence level the evolutionary relationship between these groups of enzymes is not obvious [18-20]. However, members of this super-family differ notably with respect to their assembly state: eukaryotic IPPases, PAPases and PIPases are monomeric [19,21,22], eukaryotic IMPases form homodimers as do a subset of dual activity IMPase/FBPases [16,17,23-25], whereas FBPases and the dual activity IMPase/FBPase of Thermotoga maritima form tetrameric assemblies [26,27].
###end p 22
###begin p 23
###xml 14 30 14 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 64 66 64 66 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 79 80 79 80 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 14 29 <span type="species:ncbi:1773">M. tuberculosis</span>
Comparison of M. tuberculosis SuhB to selected members of the Mg2+-dependent/Li+-inhibited phosphomonoesterase family of proteins
###end p 23
###begin p 24
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 119 120 119 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S3">3</xref>
aReferences for the pdb entries cited in this table are provided in the supplementary information [see Additional file 3].
###end p 24
###begin p 25
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
bNumber of aligned Calpha positions.
###end p 25
###begin p 26
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">c</sup>
cIMPase (inositol-1-monophosphatase), FBP (fructose-1,6-bisphosphatase), PAPase (3'-phosphoadenosine-5'-phosphatase), IPPase (inositol-polyphosphate-1-phosphatase), PIPase (inositol-polyphosphate-1-phosphatase and 3'-phosphoadenosine-5'-phosphate phosphatase)
###end p 26
###begin p 27
###xml 344 346 326 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 349 351 331 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 683 684 659 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 686 688 662 664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 869 871 838 840 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
Eukaryotic adenosine-monophosphate (AMP)-regulated FBPases have been described in terms of two sub-domains. In this description, layers I and II of the alpha-beta-alpha-beta-alpha sandwich are equivalent to the AMP-binding sub-domain of porcine FBPase, and layers III to V correspond to the fructose-1,6-bisphosphate binding sub-domain (Figure 2A) [26]. The primary sequence runs sequentially through layers I and II of the 'AMP-binding' sub-domain, but meanders in the fructose-1,6-bisphosphate-binding sub-domain between layers III-V, with helices and strands alternating. This pattern is interrupted only for strands beta12 and beta13, which are not separated by a helix (Figures 1, 2A). The dimer observed in the crystal structure of SuhB is primarily mediated by helices alpha6 in layer V and the beta-sheet in layer IV, which extends across the interface (Figure 2B). In contrast, strands in the sheet of layer II are oriented perpendicular to the plane of the dimer interface.
###end p 27
###begin p 28
###xml 304 308 290 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink">apo </italic>
###xml 343 345 329 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 377 379 363 365 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 386 388 372 374 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 316 321 <span type="species:ncbi:9606">human</span>
Due to the absence of divalent metal ions and of substrate in the active site, the loop connecting helices alpha1 and alpha2 is disordered (residues 35-53 missing), as is much of the loop connecting strands beta3 and beta4 (residues 85-96 missing). Both features are consistent with the structure of the apo form of human IMPase (pdb entry , [28]). Soaks of SuhB crystals in Mg2+- or Mn2+-containing cryoprotection buffers failed to induce ordering, or give rise to density peaks associated with metals sites known from the eukaryotic orthologues, which we attribute to the acidic pH (4.1-4.5) of the crystallisation buffer. Further disorder was seen in the hairpin loop connecting strands beta12 and beta13 (residues 254-259) in layer IV, while density for the beta9-alpha6 loop was disjointed, yet indicating that the conformation of the loop between residues 183 and 186 differed markedly between subunits. As a consequence, side chains for residues Tyr183, Val185, Arg186 and Cys187 in this loop could not be built.
###end p 28
###begin title 29
Active Site
###end title 29
###begin p 30
###xml 142 144 138 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 224 226 212 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 553 555 533 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 650 651 622 623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 894 914 866 886 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Thermotoga maritima </italic>
###xml 1080 1082 1049 1051 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 1202 1203 1171 1172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 1393 1395 1362 1364 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 539 544 <span type="species:ncbi:9606">human</span>
###xml 629 634 <span type="species:ncbi:9606">human</span>
###xml 752 757 <span type="species:ncbi:9606">human</span>
###xml 894 913 <span type="species:ncbi:2336">Thermotoga maritima</span>
###xml 1423 1428 <span type="species:ncbi:9606">human</span>
The active site of SuhB is situated in a cavity carved out at the N-terminal end of helix alpha7, sandwiched between layers II and IV (Figure 2A). Due to the disordered alpha1-alpha2 loop - referred to as the 'mobile loop' [27] - the active site in SuhB appears wide open to solvent. Yet, it is anticipated that the alpha1-alpha2 loop will become ordered upon the enzyme binding metal ions and substrate. In this state the active site is anticipated to be effectively shielded from solvent, as is the case in the ligand-bound structure of human IMPase [29]. In SuhB, the alpha1-alpha2 loop has a 10-residue insertion relative to human IMPase (Figure 1). Hence, the exact conformation of this loop in the ordered state may well deviate from that of the human enzyme. Interestingly, alternative secondary structure conformations of this loop were observed within the tetramer of the structure of Thermotoga maritima IMPase/FBPase TM1415. While the mobile loop included a short helix in two subunits of the tetramer, it assumed a beta-hairpin conformation in the other two subunits [27]. The mobile loop includes a lysine residue at position 36 (corresponding to residue 49 in SuhB, marked by I in Figure 1) that stabilizes the third of three catalytic metal sites through hydrogen bonds to two ordered water molecules. In SuhB, this lysine is conserved and parallels in the characteristics of Li+ inhibition between SuhB and human IMPase (see Discussion) suggest an equivalent pattern of interactions in the mycobacterial enzyme.
###end p 30
###begin p 31
###xml 115 118 115 118 <sup xmlns:xlink="http://www.w3.org/1999/xlink">104</sup>
###xml 124 128 124 128 <sup xmlns:xlink="http://www.w3.org/1999/xlink">109 </sup>
###xml 230 232 223 225 <sup xmlns:xlink="http://www.w3.org/1999/xlink">82</sup>
###xml 236 239 229 232 <sup xmlns:xlink="http://www.w3.org/1999/xlink">85 </sup>
###xml 287 290 274 277 <sup xmlns:xlink="http://www.w3.org/1999/xlink">209</sup>
###xml 298 302 285 289 <sup xmlns:xlink="http://www.w3.org/1999/xlink">212 </sup>
###xml 375 378 352 355 <sup xmlns:xlink="http://www.w3.org/1999/xlink">234</sup>
###xml 382 386 359 363 <sup xmlns:xlink="http://www.w3.org/1999/xlink">237 </sup>
###xml 570 573 543 546 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 641 643 614 616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 775 777 748 750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 778 780 751 753 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 781 783 754 756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 784 786 757 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 1205 1207 1178 1180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 1292 1295 1265 1268 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 1516 1518 1489 1491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 626 632 <span type="species:ncbi:9913">bovine</span>
###xml 983 988 <span type="species:ncbi:9606">human</span>
###xml 989 995 <span type="species:ncbi:9913">bovine</span>
Structural elements of the active site required for metal and substrate binding include the IMPase signature motif 104DPXDGT109 (superscripts denote residue numbers of the SuhB sequence) between strand beta4 and helix alpha4, the 82GEEG85 motif at the 'tip' of the beta3-beta4 loop, the 209G [ST]AA212 motif in the beta10-alpha7 loop, in addition to Glu228 in beta11 and the 234WDXA237 motif in helix alpha8. All elements contributing to metal site coordination are contained within one subunit of the dimeric assembly. Compelling evidence for three sites occupied by Mg2+ was provided only recently by the 1.4 A-structure of bovine IMPase [17]. This study, in conjunction with preceding structural studies on lithium-sensitive PAPase and lithium-insensitive IMPase/FBPases [21,24,25,27], provided strong support for a 3-metal catalytic reaction mechanism. When mapped onto the structure of SuhB, these three magnesium ion sites are coordinated by Glu83 (equivalent to residue 70 in human/bovine IMPase: h_70), Asp104 (h_90), Asp107 (h_93), Asp235 (h_220), in addition to the carbonyl of Ile106 (h_92). In a previous study we had shown that mutations to these sites in SuhB reduced activity dramatically [12]. Likewise, when activity was tested in the presence of various divalent cations, Mg2+ was the most potent activator of SuhB. These data and the high level of sequence conservation among active site residues justify the attempt to construct a model of inositol-1-phosphate in the active site of SuhB (Figure 3A) and to analyse potential differences in substrate-enzyme contacts.
###end p 31
###begin p 32
###xml 0 31 0 31 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Stereo views of the active site</bold>
###xml 34 35 34 35 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 600 601 592 593 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 808 812 789 793 <italic xmlns:xlink="http://www.w3.org/1999/xlink">apo </italic>
###xml 1000 1001 981 982 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 1046 1047 1023 1024 <sub xmlns:xlink="http://www.w3.org/1999/xlink">A</sub>
###xml 225 231 <span type="species:ncbi:9913">bovine</span>
###xml 249 254 <span type="species:ncbi:9606">human</span>
###xml 835 840 <span type="species:ncbi:9606">human</span>
Stereo views of the active site. (A) Active site of subunit A of SuhB, with metal sites (beige) and inositol-1-phosphate (coloured by atom type, carbons in light grey) modelled based on superimposition with the structures of bovine (PDB:, [17]) and human IMPase (PDB:, [29]). Residues in contact with metal sites and substrate in the modelled complex are shown as sticks and numbered according to the SuhB sequence. Secondary structure elements are coloured as in Figure 2A. The loop in violet indicates the approximate position of the alpha1-alpha2 loop, based on the superposition with PDB: [29]. (B) Bias-free difference density map of the beta9-alpha6 loop in SuhB, calculated after simulated annealing of the model with residues 178-188 deleted and contoured at 2sigma. The density is superimposed with apo SuhB (blue sticks) and human IMPase in complex with inositol-1-phosphate (light green, PDB:, [29]). Putative (grey) and experimental (red) contact distances with substrate are indicated. (C) Active site of subunit C of SuhB with sigmaA-weighted Fo-Fc map contoured at 3sigma, showing unexplained density around the putative substrate position and metal site 1.
###end p 32
###begin p 33
###xml 182 184 178 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 254 257 250 253 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 387 389 383 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 390 392 386 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 393 395 389 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 776 778 744 746 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 1127 1129 1089 1091 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 930 935 <span type="species:ncbi:9606">human</span>
###xml 936 942 <span type="species:ncbi:9913">bovine</span>
In our model of the SuhB-substrate complex, the phosphate moiety is positioned at the N-terminal end of helix alpha4, the helix dipole countering the charge of the phosphate (Figure 3A). Most contacts between enzyme and phosphate are through the three Mg2+ ions, with contact distances in the order of 2.15-2.3 A, in agreement with the experimental structures of the eukaryotic IMPases [17,28,29]. In addition, the phosphate forms H-bond interactions with the amide nitrogen of Gly108 (h_94) and Thr109 (h_95) at the N-terminus of helix alpha4. The inositol moiety packs primarily against residues in the beta9-alpha6 and beta10-alpha7 loops with specificity-determining contacts provided by Glu228 (h_213) in strand beta11, and Asp107 (h_93) in the beta4-alpha4 loop (Figure 3A). All conserved side chains forming the metal binding sites or contacting inositol-1-phosphate are seen in essentially the same conformation as in the human/bovine enzyme, with the exception of Glu83: as a consequence of disorder in a large part of the beta3-beta4 loop, Glu83 (h_70) in subunit A points outward rather into the active site (Figure 3A).
###end p 33
###begin p 34
###xml 38 54 38 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 228 230 221 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 240 242 233 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
###xml 364 365 350 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 552 554 538 540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
###xml 38 53 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 62 67 <span type="species:ncbi:9606">human</span>
###xml 119 124 <span type="species:ncbi:9606">human</span>
###xml 311 316 <span type="species:ncbi:9606">human</span>
###xml 833 838 <span type="species:ncbi:9606">human</span>
Significant discrepancies between the M. tuberculosis and the human enzyme are seen in the beta9-alpha6 loop, which in human IMPase provides a contact surface, but no specificity-determining interactions with the inositol ring [29] (Figure 3B). The beta9-alpha6 loop in SuhB is two residues shorter than in the human enzyme with weak sequence conservation (Figure 1). Although poorly ordered between residues 183-186, residues in proximity to the putative position of the inositol ring - Gly180, Phe181 and Gly182 - are well defined by density (Figure 3B). Interestingly, the carbonyl oxygen of Phe181 falls within H-bonding distance range of the C3 (2.9 A) and C4 (3.3 A) hydroxyls of the inositol ring, suggesting that the beta9-alpha6 of SuhB may form specificity-determining contacts to the substrate that are not present in the human enzyme.
###end p 34
###begin p 35
###xml 227 229 227 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3C</xref>
###xml 258 260 258 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 404 406 404 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 564 566 564 566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3C</xref>
A surprising observation was a patch of unexplained density in the active site that overlaps significantly with the modelled position of inositol-1-phosphate, while a second density peak coincides with the metal site 1 (Figure 3C) (in the numbering of ref. [17]). The latter is situated between the carbonyl oxygen of Ile106 and the carboxylate of Asp104 and corresponds to the high-affinity metal site [17]. The 'metal site 1' peak was present in all three active sites, whereas the density for the inositol-1-phosphate site was best defined in subunit C (Figure 3C). We consider it likely that the observed density represents a weakly-bound molecule of octyl beta-D-glucopyranoside, a reagent used as an additive during crystallisation. Whether or not the density peak a metal site 1 represents a divalent cation could not be verified.
###end p 35
###begin title 36
Dimer interface and assembly state
###end title 36
###begin p 37
###xml 858 860 822 824 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 862 864 826 828 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 1103 1105 1067 1069 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 1231 1233 1195 1197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B</xref>
###xml 459 464 <span type="species:ncbi:9606">human</span>
###xml 469 475 <span type="species:ncbi:9913">bovine</span>
###xml 1321 1326 <span type="species:ncbi:9606">human</span>
The present crystal structure comprises two apparent dimers of SuhB. One dimer is formed between the NCS-related subunits A and C, while the second dimer results from crystallographic symmetry, pairing two symmetry-related copies of subunit B. As a result of NCS restraints applied during the refinement no substantial difference between the two independent dimers is observed at the interface. The SuhB dimers also superimpose closely with the dimers of the human and bovine IMPase enzymes, whereby the dimer interface is formed by analogous secondary structure elements. These include helix alpha6, the strand beta10, the beta9-alpha 6 loop, helix alpha4, and the beta10-alpha7 and alpha7-beta11 loops. In the superposition, which is based on secondary structure matching, helices alpha6 of the two protomers are positioned opposite to each other (Figures 2B, 4A), contributing approximately 30% of the buried surface area (per monomer). It seems noteworthy that in SuhB the axes of these two helices are spaced 7.5 A apart whereas in the eukaryotic enzymes that spacing is approximately 10 A (Figure 4A). The discrepancy can be attributed to alanine residues 192 and 196 being positioned at the centre of this interface (Figure 4B), while the side chains of a leucine at position 176 occupy the corresponding space in human IMPase.
###end p 37
###begin p 38
###xml 0 27 0 27 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Analysis of dimer interface</bold>
###xml 30 31 30 31 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 333 334 329 330 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 366 371 358 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SuhB </italic>
###xml 489 490 481 482 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 87 92 <span type="species:ncbi:9606">human</span>
Analysis of dimer interface. (A) Helices alpha6 after superimposition of the dimers of human IMPase (cyan) and SuhB (red) by secondary structure matching. The spacing of the helix axes is indicated in units of A and the black oval indicates the position of the non-crystallographic 2-fold axis mapping the subunits onto each other. (B) The helix alpha6 interface in SuhB with side chains contributing to the contact surface indicated as sticks in cyan (subunit A) and yellow (subunit C). (C) Contact surface (magenta) of subunit A calculated and visualised using Swiss PDB Viewer [50]. The active site indicated by a molecule of inositol-1-phosphate (yellow sticks).
###end p 38
###begin p 39
###xml 56 58 56 58 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 110 115 110 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PISA </italic>
###xml 133 135 133 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 136 138 136 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 150 152 150 152 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 372 374 372 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4C</xref>
###xml 505 507 505 507 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 774 778 774 778 <italic xmlns:xlink="http://www.w3.org/1999/xlink">apo </italic>
###xml 809 811 809 811 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 937 939 929 931 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 948 949 940 941 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 415 420 <span type="species:ncbi:9606">human</span>
###xml 791 796 <span type="species:ncbi:9606">human</span>
The interface of the SuhB dimer buries a total of 2696 A2 of solvent accessible surface, calculated using the PISA interface server [30,31], or 1348 A2 per monomer. In terms of buried surface area hydrophobic interactions clearly dominate over H-bonds (12 contacts). Although the residues located at the interface include a number of polar and charged side chains (Figure 4C) only one ionic interaction is seen. In human IMPase distinctly more solvent accessible surface is buried in the interface (1675 A2 per monomer). Contacts across the interface include 11 ionic interactions, while the number of H-bonds (13) is about the same as in SuhB. One factor explaining the difference in size of the interface, at least in part, is the disordered 'mobile loop' in SuhB. In the apo structure of human IMPase ( - [29]), the alpha1-alpha2 loop is also disordered, reducing the total of buried solvent accessible surface per monomer from 1675 A2 to 1571 A2. Thus disorder of this loop accounts partially for the observed discrepancy.
###end p 39
###begin p 40
###xml 46 51 46 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PISA </italic>
###xml 167 172 167 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PISA </italic>
###xml 370 372 370 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 781 785 773 777 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PISA</italic>
###xml 943 944 935 936 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 1134 1137 1126 1129 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 1168 1169 1160 1161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 477 482 <span type="species:ncbi:9606">human</span>
The analysis of the dimer interface using the PISA server suggested that dimerisation of SuhB might not be constitutive. Based on molecular contacts at the interface, PISA calculates a 'complexation significance score' (CSS) that on a scale from 0 to 1 indicates the probability that a packing interface generated by crystal symmetry might represent a 'real' interface [31]. The CSS for the dimer interface of SuhB is 0.1, compared to a score of 1.0 for the dimer interface of human IMPase (with or without the alpha1-alpha2 loop in the ordered state), suggesting that dimerisation was merely due to crystal packing. We analysed self-association of SuhB by analytical ultracentrifugation (AUC) in sedimentation velocity mode. To our surprise, but consistent with the prediction by PISA, we found that SuhB is predominantly monomeric, with the peak at molecular weight 30,508 Da closely matching the calculated mass of the SuhB monomer (Figure 5). However, with increasing protein concentration a second peak at molecular weight of 54,160 Da appears, and this peak becomes more pronounced, at the expense of the main peak, when 1 mM Mg2+ is added to the buffer (Figure 5). We verified by SDS gel electrophoresis that the preparation of SuhB used in this experiment did not contain a contaminant that could explain the peak at 54,160 Da (data not shown).
###end p 40
###begin p 41
###xml 118 120 118 120 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 0 120 0 120 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Analytical ultracentrifugation in sedimentation velocity mode demonstrates that SuhB is monomeric in the absence of Mg<sup>2+</sup></bold>
###xml 181 197 181 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 276 279 276 279 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1 </sup>
###xml 311 314 311 314 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1 </sup>
###xml 344 347 344 347 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1 </sup>
###xml 361 364 361 364 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 639 641 633 635 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 181 196 <span type="species:ncbi:1773">M. tuberculosis</span>
Analytical ultracentrifugation in sedimentation velocity mode demonstrates that SuhB is monomeric in the absence of Mg2+. Main panel: Traces of the molecular weight distribution of M. tuberculosis SuhB in a sedimentation velocity experiment. Conditions analysed were 0.5 mg.ml-1 SuhB (solid triangle), 1.0 mg.ml-1 SuhB (open triangle),1.0 mg.ml-1 SuhB + 1 mM Mg2+ (open circle). The main peak is centred at 30,508 Da, the secondary peak at 54,160 Da. Inset: enlarged view of the region between 40,000 and 80,000 Da. Samples were centrifuged at 40,000 rpm, 4degreesC, for a minimum of 12 hours, in 20 mM Tris-HCl pH 7.9, 50 mM NaCl and MgCl2 as indicated.
###end p 41
###begin p 42
###xml 81 83 81 83 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1</sup>
###xml 135 137 135 137 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 662 665 662 665 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-5 </sup>
###xml 668 672 668 672 <sub xmlns:xlink="http://www.w3.org/1999/xlink">off </sub>
###xml 676 679 676 679 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-3 </sup>
###xml 680 682 680 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 780 782 780 782 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 819 822 819 822 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 869 871 869 871 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6A</xref>
###xml 884 887 884 887 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 954 956 954 956 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1</sup>
###xml 1142 1144 1142 1144 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1227 1229 1227 1229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6A</xref>
###xml 1409 1412 1409 1412 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 1485 1486 1485 1486 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S</italic>
###xml 1509 1511 1509 1511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6A</xref>
These data suggested that SuhB, at protein concentrations in the order of 1 mg.ml-1, exists in a monomer-dimer equilibrium, but that Mg2+, which is required for activity, might shift self assembly to the dimer state. The underestimate in molecular weight of the dimer peak is due to the fitting of a single frictional coefficient to two species that have differing frictional ratios. In addition, the appearance of two separate peaks in the molecular weight profile with increasing concentration indicates that the off-rate for dimerisation is slow compared with the time of sedimentation. Values for the off-rate for this regime are therefore estimated to be 10-5 < koff < 10-3 [32]. Analysing the sedimentation velocity of SuhB in the presence of increasing concentrations of Mg2+, confirmed that in the absence of Mg2+ the monomer form is strongly preferred (Figure 6A). Yet, as Mg2+ increases in concentration (at a protein concentration of 1.0 mg.ml-1) two features are observed: first, the dimer peak increases in height, at the expense of the monomer peak; second, the monomer and dimer peaks shift towards each other until, at 5 mM Mg2+, a broad skewed distribution of the sedimentation coefficient is observed (Figure 6A), suggesting a gradual transition from slow to fast exchange between the two assembly states due to an increase in the off-rate of dimerisation. Increasing the concentration of Mg2+ further, the dimer peak eventually becomes the dominant species in the c(S) distribution (Figure 6A).
###end p 42
###begin p 43
###xml 37 39 37 39 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 46 49 46 49 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 55 56 55 56 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 71 73 71 73 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 0 78 0 78 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Dimerization of SuhB is induced by Mg<sup>2+</sup>, or Mg<sup>2+ </sup>and Li<sup>+</sup>, but not by Li<sup>+ </sup>alone</bold>
###xml 183 199 183 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 226 229 226 229 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1 </sup>
###xml 276 278 276 278 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 391 393 385 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S </italic>
###xml 457 459 451 453 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S </italic>
###xml 183 198 <span type="species:ncbi:1773">M. tuberculosis</span>
Dimerization of SuhB is induced by Mg2+, or Mg2+ and Li+, but not by Li+ alone. Traces of the sedimentation coefficient distribution recorded in sedimentation velocity experiments of M. tuberculosis SuhB. SuhB was at 1.0 mg.ml-1 in 20 mM Tris-HCl pH 7.9, 50 mM NaCl, plus MgCl2 or LiCl as indicated. Samples were centrifuged at 40,000 rpm at 4degreesC for at least 12 hours. The peak at 1.6 S corresponds to a molecular weight of 30,147 Da, the peak at 2.5 S corresponds to 50,116 Da.
###end p 43
###begin p 44
###xml 42 44 42 44 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 108 111 108 111 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1 </sup>
###xml 141 143 141 143 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 176 178 176 178 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 202 204 202 204 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 295 297 295 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6B</xref>
###xml 321 323 321 323 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 381 383 381 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6B</xref>
###xml 404 405 404 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S</italic>
###xml 441 444 441 444 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 508 511 508 511 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 522 523 522 523 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 580 582 580 582 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 661 663 661 663 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 706 707 706 707 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
Next, we examined whether the inhibitor Li+ influenced dimerization. At an enzyme concentration of 1.0 mg.ml-1 and in the presence of 5 mM Mg2+, increasing concentrations of Li+ amplify the effect of Mg2+-induced dimerization, with the dimer peak becoming dominant over the monomer peak (Figure 6B). However on its own Li+ promotes dimerization only very weakly, if at all (Figure 6B). Furthermore the c(S) distribution obtained for 15 mM Mg2+ matches almost perfectly the one obtained in presence of 5 mM Mg2+ and 5 mM Li+. Calcium, which binds to IMPase on identical sites as Mg2+, but does not activate, strongly promotes dimerization, while EDTA reverses Mg2+-induced dimerization [see Additional file 1].
###end p 44
###begin title 45
Discussion
###end title 45
###begin p 46
###xml 33 49 33 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 533 535 533 535 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 630 649 630 649 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Thermotoga maritima</italic>
###xml 651 673 651 673 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Archeoglobus fulgidus </italic>
###xml 677 702 677 702 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Methanococcus jannaschii </italic>
###xml 703 705 703 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 706 708 706 708 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 709 711 709 711 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 712 714 712 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 781 784 781 784 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 840 843 840 843 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 1025 1027 1025 1027 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1030 1033 1030 1033 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50 </sub>
###xml 1042 1044 1042 1044 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 1271 1273 1271 1273 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1468 1470 1460 1462 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1688 1690 1672 1674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 1691 1693 1675 1677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 1694 1696 1678 1680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 2295 2298 2263 2266 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 2376 2378 2344 2346 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 2401 2403 2369 2371 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 2632 2633 2592 2593 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7</sup>
###xml 2708 2710 2668 2670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 2755 2757 2715 2717 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 2770 2773 2730 2733 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 2803 2805 2763 2765 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 2806 2808 2766 2768 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 2809 2811 2769 2771 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 2812 2814 2772 2774 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 2894 2895 2854 2855 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 3023 3024 2983 2984 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 3038 3040 2998 3000 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 3323 3326 3275 3278 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50 </sub>
###xml 3335 3337 3287 3289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 3458 3460 3410 3412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 33 48 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 255 260 <span type="species:ncbi:9606">human</span>
###xml 630 649 <span type="species:ncbi:2336">Thermotoga maritima</span>
###xml 677 701 <span type="species:ncbi:2190">Methanococcus jannaschii</span>
###xml 1868 1873 <span type="species:ncbi:9606">human</span>
###xml 2051 2056 <span type="species:ncbi:9606">human</span>
###xml 2863 2868 <span type="species:ncbi:9606">human</span>
The present crystal structure of M. tuberculosis SuhB confirms a highly conserved structural scaffold of IMPases in mycobacteria with respect to overall fold and active site geometry, in spite of a low level of overall sequence identity (25%) relative to human IMPase. The structural similarity correlates with similar biochemical characteristics - activation by magnesium, inhibition by lithium, specificity for inositol-1-phosphate and exclusion of fructose-1,6-bisphosphate as a substrate. It has been noted previously that the Mg2+-dependence of IMPase activity of SuhB resembles more closely that of the thermophilic species Thermotoga maritima, Archeoglobus fulgidus and Methanococcus jannaschii [12,25,33,34] in that activation is maintained over a concentration range of Mg2+ in the order of 100 mM, whereas in eukaryotic IMPases Mg2+ becomes inhibitory above 5 mM. Such comparison ignores, however, that unlike these thermophilic enzymes SuhB does not hydrolyze fructose-1,6-bisphosphate, and remains sensitive to Li+ (IC50 0.9 mM, [12]). Given that the active site of SuhB, in its 'non-mobile' part, displays the same highly conserved framework of side chains coordinating the three metal sites as the eukaryotic orthologues, we postulate that differences in Mg2+-dependence of activity between SuhB and eukaryotic IMPases must be linked on the one hand to structural differences in the mobile alpha1-alpha2 loop, and secondly to the apparent link between Mg2+-driven dimerization and activation of SuhB. In IMPases and the tetrameric IMPase/FBPases the alpha1-alpha2 loop, when ordered, stabilizes the third of the three catalytic metal sites through bridging water molecules [17,25,29]. The alpha1-alpha2 loop contributes significantly to the dimer interface. This is apparent when comparing the buried solvent-accessible surface in the dimer interface of human IMPase between the ordered and disordered state of the mobile loop. Thus, we anticipate that ordering of the alpha1-alpha2 loop in SuhB, which is 10 residues longer compared to human IMPase, will expand the dimer interface and help stabilize the dimer state. While SuhB is driven to the dimer state at high protein concentrations in the absence of metal ions, as was the case during crystallization, it is evident that Mg2+ strongly promotes dimerization at low concentrations. Lithium amplifies the Mg2+-induced effect, yet Li+ alone does not noticeably shift the monomer dimer equilibrium. These observations correlate with the characteristics of metal binding in the active site, which is known to promote ordering of the alpha1-alpha2 loop. According to 7Li-NMR binding data, lithium occupies a single site per monomer in IMPase [35], and various indirect evidence points to Li+ displacing Mg2+ from either site 2 or site 3 [17,21,36,37]. A lysine residue in the mobile loop (Lys36 in human, open asterisk in Figure 1) that coordinates the third metal site via hydrogen bonds to bridging water molecules has been shown to critically influence Li+-sensitivity [37], and this lysine is conserved in SuhB (Lys49). Given that the alpha1-alpha2 loop is disordered, the present structure leaves open the precise geometry of this loop in the ordered state and whether Lys49 in SuhB coordinates the third metal site. Yet, lithium sensitivity of SuhB (IC50 0.9 mM, [12]), the debilitating effect on activity of the W234A mutation, and the loss of Li+ inhibition through the L81A mutation [12] - a mutation that removes a stabilising hydrophobic contact to the conserved Trp234 in the active site - hint that metal binding induces ordering of the alpha1-alpha2 loop in SuhB in a similar fashion as in the eukaryotic orthologues.
###end p 46
###begin p 47
###xml 110 118 110 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 173 181 173 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 222 224 222 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 310 326 310 326 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 701 704 701 704 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 830 832 830 832 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 842 850 842 850 <italic xmlns:xlink="http://www.w3.org/1999/xlink">caveats </italic>
###xml 1010 1012 1010 1012 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 110 117 <span type="species:ncbi:562">E. coli</span>
###xml 173 180 <span type="species:ncbi:562">E. coli</span>
###xml 310 325 <span type="species:ncbi:1773">M. tuberculosis</span>
Previously, size exclusion chromatography experiments with 1 mM EDTA present in the buffer had indicated that E. coli SuhB formed monomers and it had been inferred that the E. coli enzyme was active in the monomeric form [13]. The parallels between metal-dependent self-association and enzymatic activation in M. tuberculosis SuhB strongly suggest that dimerization is linked to loading of the three metal sites in the active site, and that phosphatase activity occurs in the dimer state, although we are not in a position to determine whether dimerization is required for activity. If dimerization were required for enzymatic activity of SuhB, this would at least in part explain the wide range of Mg2+ concentrations over which activity is maintained, as the transition to the dimer state is not complete up to at least 15 mM Mg2+. Several caveats go with this rationale. First, the comparison of the activity and AUC data is complicated by the fact that metal binding is cooperative with substrate binding [38] and inositol-1-phosphate was not present in the AUC experiments. Also, while dimerisation appears to correlate with loading of the metal positions in the active site, we cannot rule out the possibility that the dimer interface contains one or more metal binding sites, which could drive dimerisation. However, the present structure, in line with related IMPases, and a series of metal-soaking experiments with SuhB crystals provided no indication for such a site (data not shown).
###end p 47
###begin p 48
###xml 116 118 116 118 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 198 200 198 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 201 203 201 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 204 206 204 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 207 209 207 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 565 567 565 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 704 707 704 707 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 765 781 765 781 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 887 889 881 883 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 934 942 928 936 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 948 950 942 944 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 956 972 950 966 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 978 980 972 974 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 1166 1168 1160 1162 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 80 85 <span type="species:ncbi:9606">human</span>
###xml 765 780 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 934 941 <span type="species:ncbi:562">E. coli</span>
###xml 956 971 <span type="species:ncbi:1773">M. tuberculosis</span>
Crystal structures of eukaryotic IMPases, a refolding study and AUC analysis of human IMPase 2, in the absence of Mg2+, consistently indicate constitutive dimerization of the eukaryotic orthologue [16,17,23,39]. It is not clear what mechanistic purpose dimerization serves with respect to the enzymatic properties of IMPases, and why dimerization should be constitutive in eukarya, but not in bacteria. Unlike the tetrameric FBPases, which are regulated by an allosteric mechanism involving changes in the relative orientation of the subunits in the tetramer (see [40] and references therein), no regulatory mechanism for IMPase has been reported that invokes dimerization of the enzyme. Nevertheless, Mg2+ has been shown to moderately enhance thermal stability of M. tuberculosis SuhB, which correlates to some extent with phosphohydrolase activity of SuhB peaking at about 80degreesC [12]. While this latter property is mirrored by E. coli SuhB [13] and M. tuberculosis CysQ [15] it has not been tested whether at such high temperatures SuhB still discriminates between substrates. Thus, while dimerization may increase thermal stability, the functional role of Mg2+-induced dimerization of SuhB in the physiological regime of the tubercle bacillus is not clear.
###end p 48
###begin title 49
###xml 32 47 <span type="species:ncbi:1773">M. tuberculosis</span>
SuhB - a template for the other M. tuberculosis IMPases?
###end title 49
###begin p 50
###xml 148 149 148 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 291 292 291 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 300 301 300 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 525 526 525 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 773 775 773 775 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 884 902 884 902 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rattus norvegicus </italic>
###xml 982 984 982 984 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 991 1003 991 1003 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T. maritima </italic>
###xml 1025 1027 1025 1027 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 1028 1030 1028 1030 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 1338 1339 1338 1339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 25 40 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 884 901 <span type="species:ncbi:10116">Rattus norvegicus</span>
###xml 991 1002 <span type="species:ncbi:2336">T. maritima</span>
The IMPase-like genes in M. tuberculosis display considerable sequence diversity relative to each other. In the multiple sequence alignment (Figure 1), SuhB and Rv3137 align with 30% sequence identity, while ImpA and CysQ score significantly lower (= 23%) relative to any sequence in Figure 1 (Table 3). Searching the PDB for homologues of known structure, using BLAST, showed that SuhB still represents the best template in terms of sequence identity, although the differences to the next nearest homologue are small (Table 3). Based on the search results, one could speculate on the substrate specificities of the two uncharacterised gene products, Rv3137 and ImpA. The gene product with the most divergent sequence, CysQ, has been characterised as a dual IMPase/FBPase [15]. Consistent with this finding, searching the PDB with the CysQ sequence returns two dual activity enzymes, Rattus norvegicus 3'-phosphoadenosine-5'-phosphate/inositol-1,4-bisphosphate phosphatase (RnPIP) [22], and T. maritima IMPase/FBPase TM1415 [18,27] as the closest homologues of known structure. Likewise, the search results mirror the close relationship of SuhB to the eukaryotic IMPases, which strongly prefer inositol-1-phosphate as substrate. Interestingly, the dual activity IMPase/FBPase TM1415 appears as the top hit for both ImpA and Rv3137 (Table 3).
###end p 50
###begin p 51
###xml 17 32 <span type="species:ncbi:1773">M. tuberculosis</span>
BLAST search for M. tuberculosis IMPase homologues of known structure
###end p 51
###begin p 52
###xml 57 62 57 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STRAP</italic>
###xml 210 216 210 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BLAST </italic>
Fields above the table diagonal give the %-identity in a STRAP-generated multiple sequence alignment. Fields in bold type give the E-values and (number of paired amino acid residues) of the two top hits in the BLAST search of the PDB [48].
###end p 52
###begin p 53
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a </sup>
a References for PDB entries:
###end p 53
###begin p 54
###xml 31 35 31 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">myo-</italic>
###xml 3 8 <span type="species:ncbi:9606">human</span>
 - human IMPase complexed with myo-inositol-1-phosphate [29]
###end p 54
###begin p 55
###xml 3 9 <span type="species:ncbi:9913">bovine</span>
 - bovine IMPase [17]
###end p 55
###begin p 56
###xml 3 21 3 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rattus norvegicus </italic>
###xml 3 20 <span type="species:ncbi:10116">Rattus norvegicus</span>
 - Rattus norvegicus 3'-phosphoadenosine 5'-phosphate and inositol-1,4-bisphosphate phosphatase [22]
###end p 56
###begin p 57
###xml 3 23 3 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Thermotoga maritima </italic>
###xml 3 22 <span type="species:ncbi:2336">Thermotoga maritima</span>
 - Thermotoga maritima TM1415 IMPase/FBPase [27]
###end p 57
###begin p 58
###xml 3 28 3 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Methanococcus jannaschii </italic>
###xml 3 27 <span type="species:ncbi:2190">Methanococcus jannaschii</span>
 - Methanococcus jannaschii MJ0109 IMPase/FBPase [24].
###end p 58
###begin p 59
###xml 63 64 63 64 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 86 87 86 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2</xref>
###xml 509 511 509 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 2002 2004 1988 1990 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 305 310 <span type="species:ncbi:9606">human</span>
###xml 495 500 <span type="species:ncbi:9606">human</span>
###xml 1234 1239 <span type="species:ncbi:9606">human</span>
Analysing the multiple sequence alignment that underlies Table 3 [see Additional file 2] more closely, it is interesting to note that enzymes that are specific for inositol-1-phosphate and exclude fructose-1,6-bisphosphate carry a glutamic acid or glutamine at position 228 (SuhB sequence; residue 213 in human IMPase), whereas Asp, His, Ser or Thr are found in enzymes that hydrolyze both substrates or are specific for fructose-1,6-bisphosphate. In the inositol-1-phosphate-bound structure of human IMPase [29], the corresponding residue, Glu213, forms hydrogen bonds to the C3 and C4 hydroxyls of the inositol ring. In addition to the H-bond between Asp93 (Asp107 in SuhB) and the C6-hydroxyl, these H-bonds are the only side chain-mediated, specificity-determining contacts between the inositol moiety and the enzyme. In the structural superimposition it is evident that an Asp (and likewise Ser, Thr or His) at this position is unlikely to confer selectivity as the distance between the terminal group of the side chain and the sugar hydroxyls becomes too large. Discrimination against fructose-1,6-bisphosphate is rooted primarily in steric clashes of the 6-phosphate the beta9-alpha6 loop. As a result of deletions relative to human IMPase, a much shorter beta9-alpha6 loop in FBPases and dual activity IMPase/FBPases provide the space to accommodate the second phosphate group. Thus, deletions in this region in addition to substitutions of Glu/Gln at position 228 could be indicative of dual specificity. Analysing the sequences of ImpA and Rv3137 in light of these considerations suggests that at least Rv3137 is restricted to inositol-1-phosphate, whereas the case is less clear cut for ImpA. The latter carries a Ser at the position corresponding to Glu228, but displays no significant deletion relative to SuhB between residues 150 and 190, whereas CysQ by the standards of both criteria falls into the category of the dual specificity enzymes, consistent with published biochemical data [15].
###end p 59
###begin title 60
Conclusion
###end title 60
###begin p 61
###xml 266 269 266 269 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 289 290 289 290 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 364 374 364 374 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bona fide </italic>
###xml 421 423 421 423 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 36 51 <span type="species:ncbi:1773">M. tuberculosis</span>
We have determined the structure of M. tuberculosis SuhB, providing a structural template for the four IMPase-like enzymes in this organism. While resembling eukaryotic IMPases in terms of structural scaffold, specificity for inositol-1-phosphate, requirement for Mg2+ and inhibition by Li+, SuhB clearly diverges from the paradigm of constitutive dimerization of bona fide IMPases. The present data support a model of Mg2+-dependent dimerization, where loading of the three catalytic metal sites in the active site induces ordering of the mobile loop, promoting dimerization likely by expanding the dimer interface. The active site of SuhB presents a highly conserved scaffold of side chains forming the metal- and substrate-binding site, yet additional specificity-determining contacts are expected with the weakly conserved beta9-alpha6 loop. Sequence and structural comparisons lead us to predict that the essential gene product Rv3137 represents a bona fide IMPase, while such may or may not be the case for ImpA.
###end p 61
###begin title 62
Methods
###end title 62
###begin title 63
Materials
###end title 63
###begin p 64
###xml 63 71 63 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 81 83 81 83 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 63 70 <span type="species:ncbi:562">E. coli</span>
Centricon YM-10 filtration units were obtained from Millipore. E. coli C41(DE3) [41], acquired from Avidis (France), was used for protein production in this study. Sparse matrix crystallisation screens were obtained from Molecular Dimensions Ltd. All other chemicals were reagent grade or better and obtained from Sigma-Aldrich.
###end p 64
###begin title 65
Expression, purification and crystallisation
###end title 65
###begin p 66
###xml 74 76 74 76 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 91 92 91 92 <sub xmlns:xlink="http://www.w3.org/1999/xlink">6</sub>
###xml 459 461 458 460 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1</sup>
Recombinant proteins were generated and purified as described previously [12]. Purified His6-tagged SuhB, was dialyzed extensively against 20 mM sodium phosphate pH 7.5, 250 mM NaCl and purified further by size exclusion chromatography over a Sephacryl S200-HR matrix. Pure fractions were pooled and concentrated using Centricon YM-10 filter units. Crystals of SuhB were obtained by hanging drop vapour diffusion, mixing 1 mul of protein solution (40-50 mg.ml-1) with 1 mul of reservoir solution, screening against commercial sparse matrix screens (Structure Screen 1 and 2, Molecular Dimensions Ltd.) at 18degreesC. Initial crystals appeared in 30%(v/v)2-methyl-2, 4-pentanediol(MPD), 0.1 M tri-sodium citrate, pH 5.6, 0.2 M ammonium acetate. Optimization led to crystals approximately 0.3 mm in length at 10-14%(v/v) MPD, 0.1 M citric acid, pH 4.2, and 0.05%(w/v) octyl beta-D-glucopyranoside. Crystals grew to their final size over 7-10 days. In preparation for X-ray data collection crystals were soaked in cryoprotectant , consisting of upto 30%(v/v) MPD, 125 mM NaCl, 0.1 M citric acid pH 4.2 and 0.05%(w/v) octyl beta-D-glucopyranoside, increasing the MPD concentration in steps of 10%. Crystals were mounted in nylon loops and frozen in a 100 K nitrogen gas stream.
###end p 66
###begin title 67
X-ray data collection and crystallographic analysis
###end title 67
###begin p 68
###xml 146 147 146 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 174 190 174 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DENZO/SCALEPACK </italic>
###xml 191 193 191 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 230 239 230 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink">POLARRFN </italic>
###xml 242 244 242 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 317 318 317 318 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 484 490 484 490 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ECALC </italic>
###xml 493 495 493 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 558 564 558 564 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AMORE </italic>
###xml 567 569 567 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 624 626 624 626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 1061 1063 1061 1063 <italic xmlns:xlink="http://www.w3.org/1999/xlink">O </italic>
###xml 1066 1068 1066 1068 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 1152 1154 1152 1154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 1248 1252 1248 1252 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CNS </italic>
###xml 1261 1263 1261 1263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 1478 1486 1478 1486 <italic xmlns:xlink="http://www.w3.org/1999/xlink">REFMAC5 </italic>
###xml 1487 1489 1487 1489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 1638 1639 1638 1639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 1721 1723 1721 1723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 602 607 <span type="species:ncbi:9606">human</span>
X-ray diffraction data for SuhB were recorded on beamline ID14-EH2 at the European Synchrotron Radiation Facility (ESRF), Grenoble, France (Table 1). Data were reduced using DENZO/SCALEPACK [42]. Patterson self-rotation analysis (POLARRFN - [43]) revealed a 3-fold non-crystallographic rotation axis parallel to the 21-screw axis (resulting in an apparent 6-fold), consistent with three SuhB monomers per crystallographic asymmetric unit. Structure factor amplitudes were normalized (ECALC - [43]), and initial phases were obtained by molecular replacement (AMORE - [43]), using monomer coordinates of human IMPase (PDB: - [29]) as a search model. While the Patterson cross-rotation search did not reveal clear solutions, the correct 3 orientations (peaks 4, 5 and 7) could be identified through comparing rotation angles between rotation function peaks with self-rotation peaks, which was confirmed through the subsequent translation search. The search model was stripped of non-conserved side chains and insertions, and built manually into MR-phased density (O - [44]). Search model bias was minimised by building into simulated annealing omit maps [45], followed by rounds of refinement (conjugate-gradient minimization, simulated annealing) in CNS ver 1.1 [46] and manual rebuilding, eventually leading to a model that fitted the data with an Rfree of ~30% (5% of reflections). Non-crystallographic symmetry restraints were introduced and the refinement was continued using REFMAC5 [47]. The final model contains 3 monomers covering SuhB residues 5-34, 54-85, 98-253, 260-286. Details of the refinement statistics are listed in Table 1. Coordinates and structure factors have been deposited in the Protein Data Bank [48] [PDB:].
###end p 68
###begin title 69
Molecular graphics
###end title 69
###begin p 70
###xml 8 9 8 9 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 11 12 11 12 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 17 22 17 22 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A,4B</xref>
###xml 43 49 43 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PyMOL </italic>
###xml 59 61 59 61 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 71 73 71 73 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4C</xref>
###xml 94 111 94 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Swiss PDB Viewer </italic>
###xml 112 114 112 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 120 128 120 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink">POV-Ray </italic>
###xml 141 143 141 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
Figures 2, 3 and 4A,4B were prepared using PyMOL ver 0.97 [49]. Figure 4C was generated using Swiss PDB Viewer [50] and POV-Ray Version 3.6 [51].
###end p 70
###begin title 71
Analytical ultracentrifugation
###end title 71
###begin p 72
###xml 233 234 233 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 239 240 239 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 591 593 585 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
Sedimentation velocity experiments were performed using a Beckman Optima XL-A analytical ultracentrifuge equipped with absorbance optics. Protein samples were dialysed into storage buffer, as indicated in the figure legends (Figures 5 and 6) and loaded into cells with two channel Epon centre pieces and quartz windows. Data were recorded at 40,000 rpm, 4degreesC. A total of 100 absorbance scans (280 nm) were recorded for each sample, representing the full extent of sedimentation of the sample. Data analysis was performed using the SEDFIT software fitting a single friction coefficient [52].
###end p 72
###begin title 73
Authors' contributions
###end title 73
###begin p 74
A.K.B., G.S.B. and K.F. designed the study. A.K.B. wrote the initial draft of the manuscript, and purified the protein. G.M. performed crystallisation experiments, data acquisition and contributed to crystallographic analysis and model building. A.K.B. and H.G. performed the AUC experiment, and with help from D.J.S., analysed the data, and prepared figures. L.G.D. together with J.N. designed and produced the expression plasmids, developed the purification protocol and contributed to data interpretation. K.F. solved the structure, contributed to design of figures, and edited the manuscript. All authors have read and approved the manuscript.
###end p 74
###begin title 75
Supplementary Material
###end title 75
###begin title 76
Additional file 1
###end title 76
###begin p 77
###xml 0 23 0 23 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Supplementary Figure S1</bold>
###xml 146 162 146 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 189 192 189 192 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1 </sup>
###xml 239 240 239 240 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 252 254 252 254 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 146 161 <span type="species:ncbi:1773">M. tuberculosis</span>
Supplementary Figure S1. This Figure shows traces of the sedimentation coefficient distribution recorded in sedimentation velocity experiments of M. tuberculosis SuhB. SuhB was at 1.0 mg.ml-1 in 20 mM Tris-HCl pH 7.9, 50 mM NaCl, plus MgCl2, LiCl, CaCl2 and EDTA as indicated. Samples were centrifuged at 40,000 rpm at 4degreesC for at least 12 hours.
###end p 77
###begin p 78
Click here for file
###end p 78
###begin title 79
Additional file 2
###end title 79
###begin p 80
###xml 0 23 0 23 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Supplementary Figure S2</bold>
###xml 110 116 110 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STRAP </italic>
###xml 117 119 117 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 140 148 140 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ESPRIPT </italic>
###xml 149 151 149 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
###xml 245 272 245 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mycobacterium tuberculosis </italic>
###xml 315 332 315 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis; </italic>
###xml 343 359 343 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 376 392 376 392 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 557 574 557 574 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 593 618 593 618 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Methanococcus jannaschii </italic>
###xml 656 678 656 678 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Archeoglobus fulgidus </italic>
###xml 716 736 716 736 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Thermotoga maritima </italic>
###xml 767 785 767 785 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rattus norvegicus </italic>
###xml 946 962 946 962 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 245 271 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
###xml 315 330 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 343 358 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 376 391 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 411 416 <span type="species:ncbi:9606">human</span>
###xml 460 465 <span type="species:ncbi:9606">human</span>
###xml 510 516 <span type="species:ncbi:9913">bovine</span>
###xml 557 573 <span type="species:ncbi:562">Escherichia coli</span>
###xml 593 617 <span type="species:ncbi:2190">Methanococcus jannaschii</span>
###xml 716 735 <span type="species:ncbi:2336">Thermotoga maritima</span>
###xml 767 784 <span type="species:ncbi:10116">Rattus norvegicus</span>
###xml 946 961 <span type="species:ncbi:1773">M. tuberculosis</span>
Supplementary Figure S2. This Figure shows a structure-based sequence alignment of IMPase-like proteins using STRAP [53] with formatting in ESPRIPT [54]. Sequence abbreviations (with pdb accession code in parentheses) are as follows: SuhB_Mtb - Mycobacterium tuberculosis SuhB ; Rv3137_Mtb - gene product Rv3131 of M. tuberculosis; ImpA_Mtb - M. tuberculosis ImpA; CysQ_Mtb - M. tuberculosis CysQ; IMPase_hum - human inositol monophosphatase (); IMPase2_hum - human inositol monophosphatase 2 (); IMPase_bov - bovine inositol monophosphatase (); SuhB_Eco - Escherichia coli SuhB; MJ0109_Mja - Methanococcus jannaschii IMPase/FBPase MJ0109 (); AF2372_Afu - Archeoglobus fulgidus IMPase/FBPase AF2372 (); TM1415_Tma - Thermotoga maritima IMPase TM1415 (); PIPase_Rno - Rattus norvegicus 3'-phosphoadenosine 5'-phosphate and inositol 1,4-bisphosphate phosphatase (). Secondary structure elements above the sequence refer to the crystal structure of M. tuberculosis SuhB.
###end p 80
###begin p 81
Click here for file
###end p 81
###begin title 82
Additional file 3
###end title 82
###begin p 83
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink">References for Table </bold>
###xml 21 22 21 22 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 85 86 85 86 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
References for Table 2. This file contains references for PDB entries cited in Table 2 of the main text.
###end p 83
###begin p 84
Click here for file
###end p 84
###begin title 85
Acknowledgements
###end title 85
###begin p 86
We thank Tom Burton for his involvement in model building as part of an undergraduate summer project. We thank Tim Dafforn for access to the analytical ultracentrifuge, part of the Biosciences Biomolecular Characterisation Facility (BBCF), and J. Baz Jackson for valuable discussions. We thank ESRF Grenoble for access to the synchrotron and travel support, and ESRF staff for support during data acquisition. G.M. was supported by an Adrian Brown Scholarship. G.S.B. acknowledges support in the form of a Personal Research Chair from Mr. James Bardrick, as a former Lister Institute-Jenner Research Fellow, and the Medical Research Council.
###end p 86
###begin article-title 87
###xml 95 101 <span type="species:ncbi:9913">bovine</span>
The effects of lithium ion and other agents on the activity of myo-inositol-1-phosphatase from bovine brain
###end article-title 87
###begin article-title 88
###xml 42 46 <span type="species:ncbi:10116">rats</span>
Reduced brain inositol in lithium-treated rats
###end article-title 88
###begin article-title 89
myo-Inositol monophosphatase: a challenging target for mood stabilising drugs
###end article-title 89
###begin article-title 90
The envelope of mycobacteria
###end article-title 90
###begin article-title 91
Mycobacterial lipoarabinomannan: an extraordinary lipoheteroglycan with profound physiological effects
###end article-title 91
###begin article-title 92
Roles of lipoarabinomannan in the pathogenesis of tuberculosis
###end article-title 92
###begin article-title 93
Relationships between the structure and the roles of lipoarabinomannans and related glycoconjugates in tuberculosis pathogenesis
###end article-title 93
###begin article-title 94
Phosphatidylinositol is an essential phospholipid of mycobacteria
###end article-title 94
###begin article-title 95
Biochemical studies on inositol. IX. D-Inositol 1-phosphate as intermediate in the biosynthesis of inositol from glucose 6-phosphate, and characteristics of two reactions in this biosynthesis
###end article-title 95
###begin article-title 96
###xml 72 95 <span type="species:ncbi:1772">Mycobacterium smegmatis</span>
Characterization and regulation of inositol monophosphatase activity in Mycobacterium smegmatis
###end article-title 96
###begin article-title 97
###xml 27 53 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence
###end article-title 97
###begin article-title 98
###xml 49 75 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
Purification and biochemical characterization of Mycobacterium tuberculosis SuhB, an inositol monophosphatase involved in inositol biosynthesis
###end article-title 98
###begin article-title 99
###xml 74 81 <span type="species:ncbi:562">E. coli</span>
Overexpression, purification, and analysis of complementation behavior of E. coli SuhB protein: comparison with bacterial and archaeal inositol monophosphatases
###end article-title 99
###begin article-title 100
Genes required for mycobacterial growth defined by high density mutagenesis
###end article-title 100
###begin article-title 101
Rv2131c gene product: an unconventional enzyme that is both inositol monophosphatase and fructose-1,6-bisphosphatase
###end article-title 101
###begin article-title 102
Structure of inositol monophosphatase, the putative target of lithium therapy
###end article-title 102
###begin article-title 103
High-resolution structure of myo-inositol monophosphatase, the putative target of lithium therapy
###end article-title 103
###begin article-title 104
MJ0109 is an enzyme that is both an inositol monophosphatase and the 'missing' archaeal fructose-1,6-bisphosphatase
###end article-title 104
###begin article-title 105
Definition of a metal-dependent/Li(+)-inhibited phosphomonoesterase protein family based upon a conserved three-dimensional core structure
###end article-title 105
###begin article-title 106
Structural similarities between fructose-1,6-bisphosphatase and inositol monophosphatase
###end article-title 106
###begin article-title 107
###xml 19 24 <span type="species:ncbi:4932">yeast</span>
X-ray structure of yeast Hal2p, a major target of lithium and sodium toxicity, and identification of framework interactions determining cation sensitivity
###end article-title 107
###begin article-title 108
Crystal structure of an enzyme displaying both inositol-polyphosphate-1-phosphatase and 3'-phosphoadenosine-5'-phosphate phosphatase activities: a novel target of lithium therapy
###end article-title 108
###begin article-title 109
###xml 21 26 <span type="species:ncbi:9606">human</span>
Crystal structure of human myo-inositol monophosphatase 2, the product of the putative susceptibility gene for bipolar disorder, schizophrenia, and febrile seizures
###end article-title 109
###begin article-title 110
Crystal structure and catalytic mechanism of the MJ0109 gene product: a bifunctional enzyme with inositol monophosphatase and fructose 1,6-bisphosphatase activities
###end article-title 110
###begin article-title 111
###xml 65 87 <span type="species:ncbi:2234">Archaeoglobus fulgidus</span>
Crystal structure of a dual activity IMPase/FBPase (AF2372) from Archaeoglobus fulgidus. The story of a mobile loop
###end article-title 111
###begin article-title 112
Crystal structure of fructose-1,6-bisphosphatase complexed with fructose 6-phosphate, AMP, and magnesium
###end article-title 112
###begin article-title 113
###xml 105 124 <span type="species:ncbi:2336">Thermotoga maritima</span>
Crystal structure of the tetrameric inositol 1-phosphate phosphatase (TM1415) from the hyperthermophile, Thermotoga maritima
###end article-title 113
###begin article-title 114
Structural studies of metal binding by inositol monophosphatase: evidence for two-metal ion catalysis
###end article-title 114
###begin article-title 115
Structural analysis of inositol monophosphatase complexes with substrates
###end article-title 115
###begin article-title 116
Protein interfaces, surfaces and assemblies service PISA at European Bioinformatics Institute
###end article-title 116
###begin article-title 117
Inference of macromolecular assemblies from crystallline state
###end article-title 117
###begin article-title 118
On the analysis of protein self-association by sedimentation velocity analytical ultracentrifugation
###end article-title 118
###begin article-title 119
###xml 65 89 <span type="species:ncbi:2190">Methanococcus jannaschii</span>
Cloning and expression of the inositol monophosphatase gene from Methanococcus jannaschii and characterization of the enzyme
###end article-title 119
###begin article-title 120
###xml 95 114 <span type="species:ncbi:2336">Thermotoga maritima</span>
Characterization of a tetrameric inositol monophosphatase from the hyperthermophilic bacterium Thermotoga maritima
###end article-title 120
###begin article-title 121
7Li nuclear-magnetic-resonance study of lithium binding to myo-inositolmonophosphatase
###end article-title 121
###begin article-title 122
###xml 55 61 <span type="species:ncbi:9913">bovine</span>
Kinetic studies with myo-inositol monophosphatase from bovine brain
###end article-title 122
###begin article-title 123
###xml 46 51 <span type="species:ncbi:9606">human</span>
The contribution of lysine-36 to catalysis by human myo-inositol monophosphatase
###end article-title 123
###begin article-title 124
Kinetic characterization of enzyme forms involved in metal ion activation and inhibition of myo-inositol monophosphatase
###end article-title 124
###begin article-title 125
Reversible unfolding of myo-inositol monophosphatase
###end article-title 125
###begin article-title 126
###xml 36 52 <span type="species:ncbi:562">Escherichia coli</span>
Novel allosteric activation site in Escherichia coli fructose-1,6-bisphosphatase
###end article-title 126
###begin article-title 127
###xml 31 47 <span type="species:ncbi:562">Escherichia coli</span>
Over-production of proteins in Escherichia coli: mutant hosts that allow synthesis of some membrane proteins and globular proteins at high levels
###end article-title 127
###begin article-title 128
Processing of X-ray diffraction data collected in oscillation mode
###end article-title 128
###begin article-title 129
The CCP4 suite: programs for protein crystallography
###end article-title 129
###begin article-title 130
Improved methods for building protein models in electron density maps and the location of errors in these models
###end article-title 130
###begin article-title 131
Model bias in crystal structures
###end article-title 131
###begin article-title 132
Crystallography & NMR system: A new software suite for macromolecular structure determination
###end article-title 132
###begin article-title 133
Refinement of macromolecular structures by the maximum-likelihood method
###end article-title 133
###begin article-title 134
The RCSB Protein Data Bank (PDB)
###end article-title 134
###begin article-title 135
The PyMOL Molecular Graphics System
###end article-title 135
###begin article-title 136
Protein structure computing in the genomic era
###end article-title 136
###begin article-title 137
PovRay - Persistence of Vision Raytracer
###end article-title 137
###begin article-title 138
Size-distribution analysis of macromolecules by sedimentation velocity ultracentrifugation and lamm equation modeling
###end article-title 138
###begin article-title 139
STRAP: editor for STRuctural Alignments of Proteins
###end article-title 139
###begin article-title 140
ESPript, Easy Sequencing in Postscript
###end article-title 140

